FDAFDA · Food and drugs·Recall number D-0012-2025
Atovaquone Oral Suspension, USP 750 mg/5 mL, 210 mL bottle, Rx only, Distributed by: Bionpharma Inc., Princeton, NJ 08540, NDC # 69452-252-87.
Published October 23, 2024 · Recall initiated: September 17, 2024
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Microbial Contamination of a Non-sterile Product: The product was found to be contaminated with Cohnella bacteria.
What to do
Voluntary: Firm initiated · Press Release
Recall details
- Brand
- ATOVAQUONE
- Manufacturer
- Bionpharma Inc.
- Distributor
- Nationwide in the U.S.A.
- UPC
- 0369452252871
- Lot
- Lot # 2310083, Exp. 09/30/2025
- Risk classification
- Class I
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.